Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study

MeSH terms

• Age Factors
• Child
• Deferiprone / administration & dosage
• Deferiprone / adverse effects
• Deferiprone / therapeutic use*
• Humans
• Iron Chelating Agents / administration & dosage
• Iron Chelating Agents / adverse effects
• Iron Chelating Agents / therapeutic use*
• Iron Overload / diagnosis
• Iron Overload / drug therapy*
• Iron Overload / etiology*
• Mediterranean Region
• Treatment Outcome
• beta-Thalassemia / complications*
• beta-Thalassemia / diagnosis
• beta-Thalassemia / therapy